CVS Group plc (LON:CVSG – Get Free Report) insider Richard Gray sold 305 shares of the stock in a transaction that occurred on Wednesday, March 26th. The shares were sold at an average price of GBX 1,007 ($13.04), for a total value of £3,071.35 ($3,976.37).
CVS Group Stock Performance
LON:CVSG traded down GBX 4 ($0.05) during trading hours on Friday, hitting GBX 1,006 ($13.02). 122,994 shares of the company traded hands, compared to its average volume of 330,204. The company has a current ratio of 1.09, a quick ratio of 0.90 and a debt-to-equity ratio of 110.52. CVS Group plc has a twelve month low of GBX 791 ($10.24) and a twelve month high of GBX 1,226 ($15.87). The firm has a 50-day moving average of GBX 1,009.33 and a 200 day moving average of GBX 960.44. The stock has a market capitalization of £721.03 million, a price-to-earnings ratio of 34.83, a P/E/G ratio of 1.77 and a beta of 1.02.
CVS Group (LON:CVSG – Get Free Report) last issued its earnings results on Thursday, February 27th. The company reported GBX 40 ($0.52) EPS for the quarter. CVS Group had a return on equity of 7.86% and a net margin of 3.20%. On average, analysts forecast that CVS Group plc will post 93.9393939 EPS for the current year.
CVS Group Company Profile
CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. It operates in animal veterinary practices and complementary veterinary diagnostic businesses.
Recommended Stories
- Five stocks we like better than CVS Group
- What Are Trending Stocks? Trending Stocks Explained
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- Consumer Staples Stocks, Explained
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- What is a penny stock? A comprehensive guide
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Receive News & Ratings for CVS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Group and related companies with MarketBeat.com's FREE daily email newsletter.